Angiotensin Receptor Antagonists Concept

subject area of

• AT ₁ Receptor Antagonist Treatment Caused Persistent Arterial Functional Changes in Young Spontaneously Hypertensive Rats  Academic Article
• Acute Kidney Injury in Patients Receiving Systemic Treatment for Cancer: A Population-Based Cohort Study  Academic Article
• Albuminuria and Decline in Cognitive Function<subtitle>The ONTARGET/TRANSCEND Studies</subtitle><alt-title>Albuminuria and Decline in Cognitive Function</alt-title>  Academic Article
• Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation  Academic Article
• Angiotensin Blockade Modulates the Activity of PD1/L1 Inhibitors in Metastatic Urothelial Carcinoma  Academic Article
• Angiotensin receptor blocker therapy and risk of cancer  Academic Article
• Angiotensin receptor blockers in heart failure: meta-analysis of randomized controlled trials  Academic Article
• Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in atherosclerosis  Academic Article
• Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers are beneficial in normotensive atherosclerotic patients: a collaborative meta-analysis of randomized trials  Academic Article
• Angiotensin-receptor blockers in prevention of cardiovascular events: are they as effective as angiotensin-converting enzyme inhibitors?  Academic Article
• Antihypertensive Drug Prescribing and Persistence Among New Elderly Users: Implications for Persistence Improvement Interventions  Academic Article
• Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis  Academic Article
• Association between angiotensin converting enzyme inhibitor or angiotensin receptor blocker use prior to major elective surgery and the risk of acute dialysis  Academic Article
• Association of Acute Increases in Plasma Creatinine after Renin-Angiotensin Blockade with Subsequent Outcomes  Academic Article
• Blockade of the renin–angiotensin–aldosterone system (RAAS) for primary prevention of non-valvular atrial fibrillation: A systematic review and meta analysis of randomized controlled trials  Academic Article
• Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis  Academic Article
• CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis  Academic Article
• Canadian Cardiovascular Society Guidelines for the Diagnosis and Management of Stable Ischemic Heart Disease  Academic Article
• Canadian Cardiovascular Society Quality Indicators for Heart Failure  Academic Article
• Candesartan cilexetil is not associated with cough in hypertensive patients with enalapril-induced cough  Academic Article
• Candesartan in heart failure—assessment of reduction in mortality and morbidity (CHARM): Rationale and design  Academic Article
• Cardiovascular and Renal Outcomes With Telmisartan, Ramipril, or Both in People at High Renal Risk  Academic Article
• Cardiovascular and cerebrovascular outcomes of long-term angiotensin receptor blockade: meta-analyses of trials in essential hypertension  Academic Article
• Clinical and pathological findings of SARS-CoV-2 infection and concurrent IgA nephropathy: a case report  Academic Article
• Clinical trials, the renin angiotensin system and atrial fibrillation  Academic Article
• Comparative Effectiveness of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in Individuals With Advanced CKD: A Nationwide Observational Cohort Study  Conference Paper
• Comparative Effects of Losartan and Enalapril on Exercise Capacity and Clinical Status in Patients With Heart Failure fn1fn1This study was supported by a grant from Merck Research Laboratories, West Point, Pennsylvania.  Academic Article
• Comparative Efficacy of Angiotensin II Antagonists in Essential Hypertension: Systematic Review and Network Meta-Analysis of Randomised Controlled Trials  Academic Article
• Comparative impact of enalapril, candesartan or metoprolol alone or in combination on ventricular remodelling in patients with congestive heart failure  Academic Article
• Covariate adjusted reanalysis of the I-Preserve trial  Academic Article
• Cross-over study comparing effects of treatment with an angiotensin converting enzyme inhibitor and an angiotensin II type 1 receptor antagonist on cardiovascular changes in hypertension  Academic Article
• Does Renin-Angiotensin System Blockade Protect Lupus Nephritis Patients From Atherosclerotic Cardiovascular Events? A Case-Control Study  Academic Article
• Effects of ACE inhibitors and angiotensin receptor blockers: protocol for a UK cohort study using routinely collected electronic health records with validation against the ONTARGET trial  Academic Article
• Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial  Academic Article
• Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial  Academic Article
• Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial  Academic Article
• Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme  Academic Article
• Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials  Academic Article
• Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography  Academic Article
• Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial  Academic Article
• Efficacy of angiotensin II receptor antagonists in preventing headache: a systematic overview and meta-analysis  Academic Article
• From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5)  Academic Article
• From the hope to the ontarget and the transcend studies: challenges in improving prognosis  Academic Article
• HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction—pharmacological approaches  Academic Article
• HR 720, a novel angiotensin receptor antagonist inhibits the angiotensin II-induced trophic effects, fibronectin release and fibronectin-EIIIA+ expression in rat aortic vascular smooth muscle cells in vitro.  Academic Article
• Heart failure.  Academic Article
• Heart failure.  Academic Article
• Heart failure.  Academic Article
• Hyperkalemia-Related Discontinuation of Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in CKD: A Population-Based Cohort Study  Academic Article
• Impact of Acarbose on Incident Diabetes and Regression to Normoglycemia in People With Coronary Heart Disease and Impaired Glucose Tolerance: Insights From the ACE Trial  Academic Article
• Impact of diabetes, angiotensin‐converting enzyme inhibitor or angiotensin II receptor blocker use, and statin use on presentation and outcomes in patients with giant cell arteritis  Conference Paper
• Initiation of sacubitril/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study  Academic Article
• Is there an optimal combination of antihypertensives for preventing cardiovascular events?  Academic Article
• Kidney Function and Potassium Monitoring After Initiation of Renin-Angiotensin-Aldosterone System Blockade Therapy and Outcomes in 2 North American Populations  Academic Article
• Length of Initial Prescription at Hospital Discharge and Long-term Medication Adherence for Elderly Patients With Coronary Artery Disease: A Population-Level Study  Academic Article
• Meta-Analysis Comparing Neurohumoral Antagonist Use in Patients ≥75 Years Versus <75 Years Receiving Cardiac Resynchronization Therapy  Academic Article
• Mineralocorticoid Receptor Antagonists in CKD: In Need of a Few Large Trials  Academic Article
• No Increase in Adverse Events During Aliskiren Use Among Ontario Patients Receiving Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers  Academic Article
• Patient Age, Ethnicity, Medical History, and Risk Factor Profile, but Not Drug Insurance Coverage, Predict Successful Attainment of Glycemic Targets  Academic Article
• Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: Putting guidelines into practice  Academic Article
• Preoperative angiotensin-converting enzyme inhibitors and angiotensin receptor blocker use and acute kidney injury in patients undergoing cardiac surgery  Academic Article
• Prevention of Atrial Fibrillation With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers  Academic Article
• Recent advances in the drug treatment of heart failure  Academic Article
• Receptor subtypes mediating spinal cardiovascular effects of angiotensin II in rat using losartan and PD 123319  Academic Article
• Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies  Academic Article
• Risk of Hospitalization for Community Acquired Pneumonia with Renin-Angiotensin Blockade in Elderly Patients: A Population-Based Study  Academic Article
• Role of Renin-Angiotensin System Blockade in Atherosclerotic Renal Artery Stenosis and Renovascular Hypertension  Academic Article
• Role of the renin-angiotensin-aldosterone system in atrial fibrillation and cardiac remodeling.  Academic Article
• Stopping Renin-Angiotensin System Inhibitors in Patients with Advanced CKD and Risk of Adverse Outcomes: A Nationwide Study  Academic Article
• Stopping renin-angiotensin system blockers after acute kidney injury and risk of adverse outcomes: parallel population-based cohort studies in English and Swedish routine care  Academic Article
• Stopping renin-angiotensin system inhibitors after hyperkalemia and risk of adverse outcomes  Academic Article
• The 2001 Canadian Cardiovascular Society consensus guideline update for the management and prevention of heart failure.  Academic Article
• The 2014 Canadian Cardiovascular Society Heart Failure Management Guidelines Focus Update: Anemia, Biomarkers, and Recent Therapeutic Trial Implications  Academic Article
• The Role of Angiotensin II Receptor Blockers in the Treatment of Heart Failure Patients  Academic Article
• The effect of renin–angiotensin–aldosterone system inhibitors on continuous and binary kidney outcomes in subgroups of patients with diabetes: a meta-analysis of randomized clinical trials  Academic Article
• The therapeutic potential of angiotensin II receptor blockers in the treatment of heart failure  Academic Article
• Underutilization of Guideline-Directed Medical Therapy in Heart Failure  Academic Article
• Use of Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers and Cardiovascular Outcomes in Chronic Dialysis Patients: A Population-Based Cohort Study  Academic Article
• Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both  Academic Article
• Withholding versus Continuing Angiotensin-converting Enzyme Inhibitors or Angiotensin II Receptor Blockers before Noncardiac Surgery  Academic Article
• Worsening renal function and outcome in heart failure patients with reduced and preserved ejection fraction and the impact of angiotensin receptor blocker treatment: data from the CHARM-study programme  Academic Article